European Journal Of Hospital Pharmacy

European Journal Of Hospital Pharmacy

欧洲医院药学杂志

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《European Journal Of Hospital Pharmacy》是由BMJ PUBLISHING GROUP出版社创办的英文国际期刊(ISSN: 2047-9956,E-ISSN: 2047-9964),该期刊长期致力于药学领域的创新研究,主要研究方向为PHARMACOLOGY & PHARMACY。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.1394...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比93.59%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在78篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

European Journal Of Hospital Pharmacy审稿周期约为 。该刊近年未被列入国际预警名单,年发文量约78篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 78 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 259 / 354

27%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 250 / 354

29.52%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.4 SJR:0.36 SNIP:0.664
学科类别 分区 排名 百分位
大类:Health Professions 小类:Pharmacy Q1 8 / 45

83%

期刊发文

  • Analysis of the clinical characteristics of dabigatran-induced oesophagitis

    Author: Zhou, Yulu; Su, Yanhong; Li, Zuojun; Wu, Cuifang; Sun, Wei; Wang, Chunjiang

    Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E24-E28. DOI: 10.1136/ejhpharm-2021-002889

  • Haemolytic anaemia induced by flutamide: a case report

    Author: Sun, Yu; Zhu, Suyan; Hu, Qi; Xu, Ping

    Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E109-E111. DOI: 10.1136/ejhpharm-2021-002936

  • Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies +/- other therapies in lung cancer: a systematic review and meta-analysis

    Author: Shen, Xiang; Huang, Shangke; Xiao, Hua; Zeng, Shan; Liu, Jiexing; Ran, Zhuolan; Xiong, Bin

    Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue 1, pp. 3-8. DOI: 10.1136/ejhpharm-2021-002803

  • Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis

    Author: Tsui, Leo; Ye, Peiying; Xu, Shiling; Lin, Yuan; Chen, Bin; Chen, Sy-Ping; Cheng, Ruoh-Yi

    Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E82-E89. DOI: 10.1136/ejhpharm-2022-003333

  • Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients

    Author: Yang, QiaoWei; Hu, Yan; Zhang, XuanLing; Zhang, XiaoMin; Li, Xingang; Dai, Haibin

    Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E90-E96. DOI: 10.1136/ejhpharm-2022-003357

  • Investigation on the knowledge level of the rational application of antimicrobial drugs among pharmacists in medical institutions in Shanxi Province

    Author: Xue, Zhimin; Guo, Zhixing; Zhao, Ruiling

    Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E19-E23. DOI: 10.1136/ejhpharm-2021-002885

  • Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients

    Author: Bai, Jing; Wen, Aiping; Li, Zhe; Li, Xingang; Duan, Meili

    Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. , Issue , pp. -. DOI: 10.1136/ejhpharm-2022-003403